Research Site — Newark, Delaware

Research Site is a clinical research site located in Newark, Delaware, United States 19713.

Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

Research Site has participated in 62 clinical trials with 18 currently active.

Therapeutic areas: Relapsing Multiple Sclerosis, Acute Coronary Syndrome, Locally Advanced (Inoperable) or Metastatic Breast Cancer.

Sponsors: Biogen, AstraZeneca, Amgen.

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site?

Research Site has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site conducted?

Research Site has 62 clinical trials on record, with 18 currently active. Their work covers Relapsing Multiple Sclerosis, Acute Coronary Syndrome, Locally Advanced (Inoperable) or Metastatic Breast Cancer.

Is Research Site accredited by Crixeo Health?

Yes — Research Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Research Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.